in remission C9102 Acute lymphoblastic leukemia, in relapse C9110 Chronic lymphocytic leuk of B-cell type not achieve remis C9111 Chronic lymphocytic leukemia of B-cell type in remission C9112 Chronic lymphocytic leukemia of B-cell type in relapse C9190 Lymphoid leukemia, unspecified not having ac...
CAR T-cells have been extensively utilized in several hematologic malignancies in recent years, and owing to their efficacy in improving patient outcomes, the FDA approved them for lymphoma and leukemia [139]. In B cell malignancies such as non-Hodgkin lymphoma, acute lymphoblastic leukemia, and c...